@article{oai:kanazawa-u.repo.nii.ac.jp:00044729,
 author = {Oda, Makoto and Kanamori, Taro and Marukawa, Yohei and Itoh, Y. and Ishikawa, Y. and Tamura, Masaya and Go, Tetsuhiko and Watanabe, Shun-ichi and Ohta, Yasuhiko and Watababe, Go and Watanabe, Yoh and 小田, 誠 and 金森, 太郎 and 丸川, 洋平 and 伊藤, 祥隆 and 石川, 暢己 and 田村, 昌也 and 呉, 哲彦 and 渡辺, 俊一 and 太田, 安彦 and 渡辺, 剛 and 渡辺, 洋宇},
 issue = {11},
 journal = {胸部外科 = 日本心臓血管外科学会雑誌, The Japanese journal of thoracic surgery},
 month = {Oct},
 note = {The purpose of this study was to evaluate the results of new TNM staging system for lung cancer in 1997, especially T3N0M0, stage IIIA, stage IIIB, and pm. Five-year survival rates of the patients with stage IIIA and stage IIIB were 16% and 18% respectively (NS). Five-year survival rates of patients with T3N1M0, T1N2M0, T2N2M0, and T3N2M0 were 40%, 28%, 15%, and 3%, respectively. The prognosis of T3N2M0 was significantly worse than that of T3N1M0, T1N2M0, and T2N2M0. Five-year survival rates of the patients excluding pm 1 with T4N0M0, T4N1M0, T4N2M0, and T4N3M0 were 21%, 10%, 10%, and 0%, respectively. The prognosis of the patients with T4N0 was significantly better than that of T4N2 and T4N3. In the patients with pm, 5-year survival rates of the patients with pm 1 and pm 2 were 26% and 7%, respectively (p < 0.01). In the patients with pm 1, 5-year survival rates of the patients with N0 + N1 and N1 + N2 were 53% and 16%, respectively (p < 0.01). From our these results, we supported the new TNM system as putting T3N0M0 to stage IIB, putting pm 2 into stage IV. We proposed; 1) chest wall invasion with bone destruction stay in stage IIIA or is T4, 2) T3N1M0 is classified with stage IIB, 3) main stem bronchus invasion is classified with T2, 4) pm 1 is subdivide by N status. Furthermore, stage III seemed to be reasonably subdivided into T1-2N3M0, T4N0-1M0 as stage IIIA and T3-4N2, T1-4N3 as stage IIIB., 金沢大学医薬保健研究域医学系},
 pages = {905--909},
 title = {肺癌の手術成績からみた新病期分類, とくにIIIA期, IIIB期の妥当性と問題点},
 volume = {53},
 year = {2000}
}